SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: Steve Harmon who wrote (1163)6/3/1998 10:16:00 AM
From: Dr. John M. de Castro  Read Replies (1) | Respond to of 2742
 
Here's another hypothesis. If Bluestone is trying to sell or merge the company, it would make sense to keep the stock price low. This simply makes CIST even more of a bargain for a potential buyer. At current levels, an acquiring company could offer a 100% premium and still be getting a bargain.

John de C